{"nctId":"NCT00542789","briefTitle":"Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID","startDateStruct":{"date":"2007-08"},"conditions":["Gastric Ulcer","Duodenal Ulcer","Rheumatoid Arthritis","Osteoarthritis","Lumbago"],"count":343,"armGroups":[{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Esomeprazole"]}],"interventions":[{"name":"Esomeprazole","otherNames":["Nexium"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Medical history of gastric and/or duodenal ulcer\n* A diagnosis of a chronic condition (rheumatoid arthritis, osteoarthritis, lumbago,etc) that requires daily NSAID use,at least 20 years of age\n\nExclusion Criteria:\n\n* Having gastric or duodenal ulcer in active or healing stage according to the Sakita/Miwa classification\n* History of esophageal, gastric or duodenal surgery\n* Having severe liver disease or chronic renal disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absence of Gastric and/or Duodenal Ulcer Throughout the Treatment Period","description":"The absence of gastric and/or duodenal ulcer throughout the treatment period","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167","spread":null},{"groupId":"OG001","value":"112","spread":null}]}]}]},{"type":"SECONDARY","title":"Absence of Gastric and/or Duodenal Ulcer up to 4 Weeks After Treatment","description":"The absence of gastric and/or duodenal ulcer up to 4 weeks after treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"172","spread":null},{"groupId":"OG001","value":"133","spread":null}]}]}]},{"type":"SECONDARY","title":"Absence of Gastric and/or Duodenal Ulcer up to 12 Weeks After Treatment","description":"The absence of gastric and/or duodenal ulcer up to 12 weeks after treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"168","spread":null},{"groupId":"OG001","value":"119","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":12,"n":173},"commonTop":["Nasopharyngitis","Abdominal Pain Upper","Stomach Discomfort","Abdominal Distension","Reflux Oesophagitis"]}}}